New England Journal of Medicine最新文献

筛选
英文 中文
Colchicine and Spironolactone in Acute Myocardial Infarction. 秋水仙碱与螺内酯治疗急性心肌梗死。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMc2503896
Michele Golino, Benjamin Van Tassell, Antonio Abbate
{"title":"Colchicine and Spironolactone in Acute Myocardial Infarction.","authors":"Michele Golino, Benjamin Van Tassell, Antonio Abbate","doi":"10.1056/NEJMc2503896","DOIUrl":"https://doi.org/10.1056/NEJMc2503896","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2073-2074"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. 索特塞普在肺动脉高压高危死亡患者中的作用。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 Epub Date: 2025-03-31 DOI: 10.1056/NEJMoa2415160
Marc Humbert, Vallerie V McLaughlin, David B Badesch, H Ardeschir Ghofrani, J Simon R Gibbs, Mardi Gomberg-Maitland, Ioana R Preston, Rogerio Souza, Aaron B Waxman, Victor M Moles, Laurent Savale, Carmine Dario Vizza, Stephan Rosenkranz, Yaru Shi, Barry Miller, Harald S Mackenzie, Samuel S Kim, Maria José Loureiro, Mahesh J Patel, Joerg Koglin, Alexandra G Cornell, Marius M Hoeper
{"title":"Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.","authors":"Marc Humbert, Vallerie V McLaughlin, David B Badesch, H Ardeschir Ghofrani, J Simon R Gibbs, Mardi Gomberg-Maitland, Ioana R Preston, Rogerio Souza, Aaron B Waxman, Victor M Moles, Laurent Savale, Carmine Dario Vizza, Stephan Rosenkranz, Yaru Shi, Barry Miller, Harald S Mackenzie, Samuel S Kim, Maria José Loureiro, Mahesh J Patel, Joerg Koglin, Alexandra G Cornell, Marius M Hoeper","doi":"10.1056/NEJMoa2415160","DOIUrl":"10.1056/NEJMoa2415160","url":null,"abstract":"<p><strong>Background: </strong>Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The effects of add-on sotatercept in patients with advanced pulmonary arterial hypertension and a high risk of death are unclear.</p><p><strong>Methods: </strong>In this phase 3 trial, we randomly assigned patients with pulmonary arterial hypertension (WHO functional class III or IV) and a high 1-year risk of death (Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management Lite 2 risk score, ≥9) who were receiving the maximum tolerated dose of background therapy to receive add-on sotatercept (starting dose, 0.3 mg per kilogram of body weight; escalated to target dose, 0.7 mg per kilogram) or placebo every 3 weeks. The primary end point was a composite of death from any cause, lung transplantation, or hospitalization (≥24 hours) for worsening pulmonary arterial hypertension, assessed in a time-to-first-event analysis.</p><p><strong>Results: </strong>A total of 172 patients were included (86 each in the sotatercept and placebo groups). The trial was stopped early on the basis of the efficacy results of a prespecified interim analysis. At least one primary end-point event occurred in 15 patients (17.4%) in the sotatercept group and in 47 patients (54.7%) in the placebo group (hazard ratio, 0.24; 95% confidence interval, 0.13 to 0.43; P<0.001). Death from any cause occurred in 7 patients (8.1%) in the sotatercept group and in 13 patients (15.1%) in the placebo group; lung transplantation in 1 patient (1.2%) and 6 patients (7.0%), respectively; and hospitalization for worsening pulmonary arterial hypertension in 8 patients (9.3%) and 43 patients (50.0%). The most common adverse events with sotatercept were epistaxis and telangiectasia.</p><p><strong>Conclusions: </strong>Among high-risk adults with pulmonary arterial hypertension who were receiving the maximum tolerated dose of background therapy, treatment with sotatercept resulted in a lower risk of a composite of death from any cause, lung transplantation, or hospitalization (≥24 hours) for worsening pulmonary arterial hypertension than placebo. (Funded by Merck Sharp and Dohme, a subsidiary of Merck [Rahway, NJ]; ZENITH ClinicalTrials.gov number, NCT04896008.).</p>","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"1987-2000"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and Treatment of Alcohol Use Disorder. Reply. 酒精使用障碍的识别和治疗。回复。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMc2502755
Paul S Haber
{"title":"Identification and Treatment of Alcohol Use Disorder. Reply.","authors":"Paul S Haber","doi":"10.1056/NEJMc2502755","DOIUrl":"https://doi.org/10.1056/NEJMc2502755","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2079"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin-Derived Amyloidosis. Insulin-Derived淀粉样变。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMicm2415719
Daniel Connors, Philip Chia
{"title":"Insulin-Derived Amyloidosis.","authors":"Daniel Connors, Philip Chia","doi":"10.1056/NEJMicm2415719","DOIUrl":"https://doi.org/10.1056/NEJMicm2415719","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"e50"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colchicine and Spironolactone in Acute Myocardial Infarction. Reply. 秋水仙碱与螺内酯治疗急性心肌梗死。回复。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMc2503896
Sanjit S Jolly, Marc-André d'Entremont, Rajibul Mian
{"title":"Colchicine and Spironolactone in Acute Myocardial Infarction. Reply.","authors":"Sanjit S Jolly, Marc-André d'Entremont, Rajibul Mian","doi":"10.1056/NEJMc2503896","DOIUrl":"https://doi.org/10.1056/NEJMc2503896","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2075"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer of Unknown Primary Site. 原发部位未知的癌症。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMcp2402691
Kanwal Raghav
{"title":"Cancer of Unknown Primary Site.","authors":"Kanwal Raghav","doi":"10.1056/NEJMcp2402691","DOIUrl":"https://doi.org/10.1056/NEJMcp2402691","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2035-2047"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colchicine and Spironolactone in Acute Myocardial Infarction. 秋水仙碱与螺内酯治疗急性心肌梗死。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMc2503896
Hong-Qiu Gu, Yong Jiang, Hao Li
{"title":"Colchicine and Spironolactone in Acute Myocardial Infarction.","authors":"Hong-Qiu Gu, Yong Jiang, Hao Li","doi":"10.1056/NEJMc2503896","DOIUrl":"https://doi.org/10.1056/NEJMc2503896","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2072-2073"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Superior Mesenteric Vein Thrombosis and Small-Bowel Infarction. 急性肠系膜上静脉血栓和小肠梗死。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMicm2500451
Chih-Yang Hsiao, Chih-Yang Chan
{"title":"Acute Superior Mesenteric Vein Thrombosis and Small-Bowel Infarction.","authors":"Chih-Yang Hsiao, Chih-Yang Chan","doi":"10.1056/NEJMicm2500451","DOIUrl":"https://doi.org/10.1056/NEJMicm2500451","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2048"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colchicine and Spironolactone in Acute Myocardial Infarction. 秋水仙碱与螺内酯治疗急性心肌梗死。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMc2503896
Jörg Striessnig
{"title":"Colchicine and Spironolactone in Acute Myocardial Infarction.","authors":"Jörg Striessnig","doi":"10.1056/NEJMc2503896","DOIUrl":"https://doi.org/10.1056/NEJMc2503896","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2071-2072"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colchicine and Spironolactone in Acute Myocardial Infarction. 秋水仙碱与螺内酯治疗急性心肌梗死。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-29 DOI: 10.1056/NEJMc2503896
Yujiro Kida
{"title":"Colchicine and Spironolactone in Acute Myocardial Infarction.","authors":"Yujiro Kida","doi":"10.1056/NEJMc2503896","DOIUrl":"https://doi.org/10.1056/NEJMc2503896","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 20","pages":"2073"},"PeriodicalIF":96.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信